Tivic Health Systems, Inc.
- TIVC
- NASDAQ
- Medical - Specialties
- Immunotherapeutics (TLR5 Agonist)
- Radiation Syndrome Treatment
$0.26
Today −10.46%Quote Jul 29, 2026, 07:59 PM UTC
+177.07%over the last month
Max drawdown −45.6%From 1-month high 0.0%3 months +12.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$871,025.227
Approximate share count
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$0.25
2.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TIVCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Specialties
Employees
52
Founded
2016